Results 41 to 50 of about 65,570 (200)

Polypharmacy and Excessive Polypharmacy Among Persons Living with Chronic Pain: A Cross-Sectional Study on the Prevalence and Associated Factors

, 2023
Ghita Zahlan,1 Gwenaelle De Clifford-Faugère,1 Hermine Lore Nguena Nguefack,1 Line Guénette,2,3 M Gabrielle Pagé,4,5 Lucie Blais,6 Anaïs Lacasse1 1Département des sciences de la santé, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, Quebec,
Zahlan G, Blais L, Guénette L, Pagé MG, De Clifford-Faugère G, Nguena Nguefack HL, Lacasse A   +6 more
core  

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia [PDF]

, 2022
BACKGROUND: In clinical practice, different antipsychotics can be combined in the treatment of people with schizophrenia (polypharmacy). This strategy can aim at increasing efficacy, but might also increase the adverse effects due to drug–drug ...
Myrto T Samara, Stefan Leucht, Samara, Myrto T, Samara, Myrto T., Leucht, Stefan, Wulf-Peter Hansen, Ingrid Bauer, Cutrufelli, Pierfelice, Spyridon Siafis, Baeckers, Lio, Salvatore Salomone, Eugenio Aguglia, Bighelli, Irene, Siafis, Spyridon, Hansen, Wulf-Peter, Salomone, Salvatore, Aguglia, Eugenio, Bauer, Ingrid, Rodolico, Alessandro, Irene Bighelli, Pierfelice Cutrufelli, Alessandro Rodolico, Lio Baeckers   +22 more
core   +2 more sources

Defining pediatric polypharmacy: A scoping review.

PLoS ONE, 2018
ObjectivesLack of consensus regarding the semantics and definitions of pediatric polypharmacy challenges researchers and clinicians alike. We conducted a scoping review to describe definitions and terminology of pediatric polypharmacy.MethodsMedline ...
Paul M Bakaki, Alexis Horace, Neal Dawson, Almut Winterstein, Jennifer Waldron, Jennifer Staley, Elia M Pestana Knight, Sharon B Meropol, Rujia Liu, Hannah Johnson, Negar Golchin, James A Feinstein, Shari D Bolen, Lawrence C Kleinman   +13 more
doaj   +1 more source

Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil [PDF]

Revista Brasileira de Epidemiologia, 2020
: Objective: To estimate the prevalence of polypharmacy, describe the pharmacotherapeutic classes used, and investigate whether polypharmacy is associated with demographic and socioeconomic indicators, regardless of the number of diseases, among ...
Isabella Ribeiro Silva, Luana Giatti, Dora Chor, Maria de Jesus Mendes da Fonseca, Sotero Serrate Mengue, Francisco de Assis Acurcio, Mariana Linhares Pereira, Sandhi Maria Barreto, Roberta Carvalho de Figueiredo   +8 more
doaj   +1 more source

Polypharmacy and associated factors in South Korean elderly patients with dementia: An analysis using National Health Insurance claims data.

PLoS ONE
BackgroundDementia is accompanied by several symptoms, including cognitive function decline, as well as behavioral and psychological symptoms. Elderly patients with dementia often experience polypharmacy, the concurrent use of multiple medications, due ...
Hea-Lim Kim, Hye-Jae Lee
doaj   +1 more source

Variation of polypharmacy in older primary care attenders occurs at prescriber level

BMC Geriatrics, 2018
Background Polypharmacy is particularly important in older persons as they are more likely to experience adverse events compared to the rest of the population.
Su Miin Ong, Yvonne Mei Fong Lim, Sheamini Sivasampu, Ee Ming Khoo   +3 more
doaj   +1 more source

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis

JGH Open, 2023
Background and Aim Polypharmacy and sarcopenia are increasing public health problems worldwide. However, data on the prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis are limited. Methods
Tatsunori Hanai, Kayoko Nishimura, Takao Miwa, Toshihide Maeda, Kenji Imai, Atsushi Suetsugu, Koji Takai, Masahito Shimizu   +7 more
doaj   +1 more source

A qualitative exploration of factors contributing to non-guideline adherent antipsychotic polypharmacy

, 2021
Background: Antipsychotic polypharmacy (“polypharmacy”) involves the concurrent prescribing of two or more antipsychotics for managing schizophrenia. It occurs frequently despite there being limited clinical evidence for this practice and an increased ...
Lim, S, Hattingh, L, Chalmers, L, Sunderland, B, Nguyen, ML   +4 more
core   +1 more source

Polypharmacy and excessive polypharmacy in community-dwelling middle aged and aged adults between 2011 and 2015 [PDF]

, 2021
AIMS: We aimed to assess the prevalence, components and evolution of polypharmacy and to evaluate risk factors associated with polypharmacy. METHODS: A retrospective dynamic cohort study was performed, using a primary healthcare database comprising ...
van den Akker, Marjan, van den Akker, M., Van Pottelbergh, G., Spriet, Isabel, Vaes, Bert, Hellemans, Laura, Van Pottelbergh, Gijs, Hias, Julie, Rygaert, Xavier, van der Linden, Lorenz, Nuyts, S., Tournoy, Jos, Hellemans, L., Nuyts, Shauni, Rygaert, X., Hias, J., Spriet, I., van der Linden, L., Tournoy, J., Vaes, B.   +19 more
core   +1 more source

Polypharmacy and Potential Drug Interactions Causing Neurological Symptoms in Geriatric Patients with Epilepsy

, 2022
Objective:Polypharmacy brings with it the risk of potential drug interaction. This study aimed to investigate polypharmacy, potential drug interactions, the drug interactions causing neurological symptoms in geriatric patients with epilepsy, and ...
Bahar Erbaş
core   +1 more source